New Study Begins for a Novel Treatment to Control High Phosphate Levels in Dialysis Patients
R1 Therapeutics has started a global phase 2b clinical trial for a new medication called AP306, designed to treat high […]
R1 Therapeutics has started a global phase 2b clinical trial for a new medication called AP306, designed to treat high […]
The European Pharmacopoeia Commission has published an updated chapter (5.1.6) on alternative microbiological testing methods, making it easier for professionals
Scientists have made progress in developing a dissolvable microneedle patch that could store and deliver mRNA vaccines without the need
Eisai and Biogen, two pharmaceutical companies, have received approval from the U.S. Food and Drug Administration (FDA) for a new
Scientists have discovered that a genetically engineered version of a common gut bacteria, called Bifidobacterium longum, could help boost the
AstraZeneca, a major pharmaceutical company, has made a significant agreement with Dizal Pharmaceutical, a Chinese drug developer, to gain worldwide
EpilepsyGTx, a company working on new treatments for epilepsy, has teamed up with ClearPoint Neuro to use a specialized tool
Pharmacists and companies that hold Certificates of Suitability for European Pharmacopoeia (CEP) are being asked to review and provide feedback
A major new clinical trial called PRECISE-HD has started to test whether a drug called pridopidine can help people with
A major update was shared at the ISSCR 2026 Annual Meeting about the first clinical trial testing a new treatment